Unlike CTLA-4 ligands, earlier studies pointed out that PD-1 ligands are selectively expressed in various cancers as well as within tumor microenvironments (49, 50); specifically, PD-1 was found to be quite prominent in various solid and hematological malignancies (49–54). Here, CTLA4 is linked to neoplasm.